 SOUTH PLAINFIELD, N.J., Aug. 23, 2021 PRNewswire -- PTC Therapeutics, Inc. NASDAQ: PTCT today announced the publication of a manuscript, Gene Therapy in the Putamen for Curing AADC Deficiency and Parkinsons Disease, in the European Molecular Biology Organization Journal. 